dicyclomine
Generic: DICYCLOMINE HYDROCHLORIDE·Brand: BENTYL, BENTYL PRESERVATIVE FREE, Bentyl, DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
dicyclomine: developed by 1 company · 1 FDA decision.
dicyclomine evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect dicyclomine to NEXS; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could dicyclomine → NEXS affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
Development Pipeline (2)
| Company | Phase |
|---|---|
| NEXUS BIOPHARMA INC (NEXS) | Approved |
| NEXUS BIOPHARMA INC (NEXS) | Approved |
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE Dicyclomine hydrochloride capsules, USP are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome (1)(NEXS)FDA ↗
ANDA206468UNKNOWNStandardOtherInjectable
Frequently asked questions
Who is developing dicyclomine?
dicyclomine is being developed by NEXUS BIOPHARMA INC.
What is dicyclomine's latest FDA decision?
The most recent tracked FDA decision for dicyclomine is Approval for 1 INDICATIONS AND USAGE Dicyclomine hydrochloride capsules, USP are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome (1), dated February 1, 2019.